| Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes B Bartosch, J Dubuisson, FL Cosset The Journal of experimental medicine 197 (5), 633-642, 2003 | 1503 | 2003 |
| Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras T Pietschmann, A Kaul, G Koutsoudakis, A Shavinskaya, S Kallis, ... Proceedings of the National Academy of Sciences 103 (19), 7408-7413, 2006 | 901 | 2006 |
| Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor B Bartosch, A Vitelli, C Granier, C Goujon, J Dubuisson, S Pascale, ... Journal of Biological Chemistry 278 (43), 41624-41630, 2003 | 849 | 2003 |
| EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana, L Zona, C Davis, ... Nature medicine 17 (5), 589-595, 2011 | 835 | 2011 |
| High-titer packaging cells producing recombinant retroviruses resistant to human serum FL Cosset, Y Takeuchi, JL Battini, RA Weiss, MK Collins Journal of virology 69 (12), 7430-7436, 1995 | 830 | 1995 |
| An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor JL Blond, D Lavillette, V Cheynet, O Bouton, G Oriol, S Chapel-Fernandes, ... Journal of virology 74 (7), 3321-3329, 2000 | 823 | 2000 |
| Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C JM Pestka, MB Zeisel, E Bläser, P Schürmann, B Bartosch, FL Cosset, ... Proceedings of the National Academy of Sciences 104 (14), 6025-6030, 2007 | 664 | 2007 |
| Viral vectors: from virology to transgene expression D Bouard, N Alazard‐Dany, FL Cosset British journal of pharmacology 157 (2), 153-165, 2009 | 488 | 2009 |
| In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes B Bartosch, J Bukh, JC Meunier, C Granier, RE Engle, WC Blackwelder, ... Proceedings of the National Academy of Sciences 100 (24), 14199-14204, 2003 | 445 | 2003 |
| Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells … V Sandrin, B Boson, P Salmon, W Gay, D Negre, R Le Grand, D Trono, ... Blood, The Journal of the American Society of Hematology 100 (3), 823-832, 2002 | 393 | 2002 |
| An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of … B Bartosch, G Verney, M Dreux, P Donot, Y Morice, F Penin, JM Pawlotsky, ... Journal of virology 79 (13), 8217-8229, 2005 | 377 | 2005 |
| Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins A Goffard, N Callens, B Bartosch, C Wychowski, FL Cosset, C Montpellier, ... Journal of virology 79 (13), 8400-8409, 2005 | 364 | 2005 |
| Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus D Lavillette, AW Tarr, C Voisset, P Donot, B Bartosch, C Bain, AH Patel, ... Hepatology 41 (2), 265-274, 2005 | 353 | 2005 |
| Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus … D Lavillette, Y Morice, G Germanidis, P Donot, A Soulier, E Pagkalos, ... Journal of virology 79 (10), 6023-6034, 2005 | 351 | 2005 |
| Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein A Owsianka, AW Tarr, VS Juttla, D Lavillette, B Bartosch, FL Cosset, ... Journal of virology 79 (17), 11095-11104, 2005 | 340 | 2005 |
| Virology and cell biology of the hepatitis C virus life cycle–An update J Dubuisson, FL Cosset Journal of hepatology 61 (1), S3-S13, 2014 | 337 | 2014 |
| Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 MB Zeisel, G Koutsoudakis, EK Schnober, A Haberstroh, HE Blum, ... Hepatology 46 (6), 1722-1731, 2007 | 335 | 2007 |
| Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase Y Takeuchi, CD Porter, KM Strahan, AF Preece, K Gustafsson, FL Cosset, ... Nature 379 (6560), 85-88, 1996 | 335 | 1996 |
| Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 JC Meunier, RE Engle, K Faulk, M Zhao, B Bartosch, H Alter, SU Emerson, ... Proceedings of the National Academy of Sciences 102 (12), 4560-4565, 2005 | 333 | 2005 |
| Retroviral retargeting by envelopes expressing an N-terminal binding domain FL Cosset, FJ Morling, Y Takeuchi, RA Weiss, MK Collins, SJ Russell Journal of virology 69 (10), 6314-6322, 1995 | 319 | 1995 |
